Form 4: Eli Lilly Executive Edgardo Hernandez Reports Stock Transactions

EVP & Pres., Mfg. Operations Edgardo Hernandez reports acquisition of common stock and restricted stock units, along with a disposition of common stock.

Summary

• Edgardo Hernandez, an Executive Vice President at Eli Lilly & Co, filed a Form 4 detailing changes in beneficial ownership.
• On February 10, 2025, Hernandez acquired 5,974.141 shares of common stock at a price of $868.88 per share.
• On the same date, Hernandez disposed of some common stock.
• Following these transactions, Hernandez directly owns 38,171.76 shares of common stock.
• Hernandez also indirectly owns 866.62 shares through a 401(k).
• Additionally, Hernandez acquired 3,572 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable on February 1, 2026, and expiring on February 1, 2026.

Sentiment

Score: 5

Explanation: The document is a regulatory filing detailing stock transactions, which is neutral in sentiment. The acquisition and disposition of shares balance each other out.

Positives

• The acquisition of common stock and restricted stock units by an executive could be interpreted as a positive signal, indicating confidence in the company's future performance.

Negatives

• The disposition of common stock by the executive could be interpreted as a negative signal.

Risks

• Executive stock transactions are subject to various regulations and internal policies to prevent insider trading, and any violations could lead to legal and reputational risks.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's prospects.

Stakeholder Impact

• The stock transactions may influence investor sentiment and potentially impact the company's stock price.

Key Dates